EmPAC (reformulated paclitaxel)
/ Cornerstone Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 7
Of
7
Go to page
1
April 22, 2026
The EMPAC Tool: Development and Validation of a Context-Specific Questionnaire for Measuring Patient-Centered Surgical Care in Sub-Saharan Africa.
(PubMed, World J Surg)
- "A novel parsimonious scale for measuring PCSC, a first of its kind for SSA, was developed using standard instrument development guidelines. The scale has shown evidence for reliability and construct validity paving the way for further validation among surgical patients in similar settings. The test-retest reliability, which was conducted on a sample of only 57 participants from four different study sites, was moderate to low (ICC: 0.61) pointing to the need for further evaluation using a larger sample size."
Journal
March 18, 2026
EMPAC-BDD: TMS Visual Modulation in Body Dysmorphic Disorder
(clinicaltrials.gov)
- P=N/A | N=40 | Completed | Sponsor: Centre for Addiction and Mental Health | Recruiting ➔ Completed | Trial completion date: Oct 2025 ➔ Jun 2025
Trial completion • Trial completion date • CNS Disorders • Psychosomatic Disorders
February 24, 2025
EMPAC-BDD: TMS Visual Modulation in Body Dysmorphic Disorder
(clinicaltrials.gov)
- P=N/A | N=40 | Recruiting | Sponsor: Centre for Addiction and Mental Health | Trial completion date: Oct 2024 ➔ Oct 2025 | Trial primary completion date: Jul 2024 ➔ Jul 2025
Trial completion date • Trial primary completion date • CNS Disorders • Psychosomatic Disorders
May 23, 2023
EMPAC-BDD: TMS Visual Modulation in Body Dysmorphic Disorder
(clinicaltrials.gov)
- P=N/A | N=40 | Recruiting | Sponsor: Centre for Addiction and Mental Health | Not yet recruiting ➔ Recruiting
Enrollment open • CNS Disorders • Psychosomatic Disorders
February 08, 2023
EMPAC-BDD: TMS Visual Modulation in Body Dysmorphic Disorder
(clinicaltrials.gov)
- P=N/A | N=40 | Not yet recruiting | Sponsor: Centre for Addiction and Mental Health | Initiation date: Dec 2022 ➔ Mar 2023
Trial initiation date • CNS Disorders • Psychosomatic Disorders
November 07, 2022
EMPAC-BDD: TMS Visual Modulation in Body Dysmorphic Disorder
(clinicaltrials.gov)
- P=N/A | N=40 | Not yet recruiting | Sponsor: Centre for Addiction and Mental Health
New trial • CNS Disorders • Psychosomatic Disorders
December 15, 2021
"Así se empacó la tuya @manu_barreiro jejejeje"
(,@puentesfabi)
1 to 7
Of
7
Go to page
1